These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33015935)

  • 1. Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Gadkaree SK; McCarty JC; Feng AL; Siu JM; Burks CA; Deschler DG; Richmon JD; Varvares MA; Bergmark RW
    Head Neck; 2021 Feb; 43(2):438-448. PubMed ID: 33015935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival differences among American Indians/Alaska Natives with head and neck squamous cell carcinoma.
    Dwojak SM; Sequist TD; Emerick K; Deschler DG
    Head Neck; 2013 Aug; 35(8):1114-8. PubMed ID: 22887354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Multidisciplinary Care of Head and Neck Squamous Cell Carcinoma in Medicare Patients.
    Hansen CC; Egleston B; Leachman BK; Churilla TM; DeMora L; Ebersole B; Bauman JR; Liu JC; Ridge JA; Galloway TJ
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1136-1146. PubMed ID: 33090191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
    Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
    Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma.
    Xu C; Chen YP; Liu X; Tang LL; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Li WF; Lin AH; Sun Y; Ma J
    Cancer Sci; 2017 Jun; 108(6):1253-1262. PubMed ID: 28383806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Choice of Nonsurgical Treatment Contributes to Disparities in Head and Neck Squamous Cell Carcinoma.
    Parhar HS; Anderson DW; Janjua AS; Durham JS; Prisman E
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1057-1064. PubMed ID: 29436282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Guideline-Concordant Care and Its Effect on Survival in Black Patients with Head and Neck Cancers: A SEER-Medicare Analysis.
    Vyfhuis MAL; Suzuki I; Bentzen SM; Cullen KJ; Goloubeva OG
    Oncologist; 2021 Jul; 26(7):579-587. PubMed ID: 33783061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the pandemic on the presentation and treatment of head and neck squamous cell carcinoma at a county hospital.
    Allen DZ; Ahmad JG; McKee SP; Suarez N; Basmaci UN; Alava I
    Am J Otolaryngol; 2024; 45(1):104103. PubMed ID: 37988796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.
    Birkeland AC; Rosko AJ; Chinn SB; Prince ME; Sun GH; Spector ME
    ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):61-9. PubMed ID: 26910465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
    Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second primary lung malignancy following head and neck squamous cell carcinoma.
    Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
    Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
    Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
    Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "Medicare effect" on head and neck cancer diagnosis and survival.
    Smith JB; Jayanth P; Hong SA; Simpson MC; Massa ST
    Head Neck; 2023 Jul; 45(7):1663-1675. PubMed ID: 37096786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival Outcomes in Early Stage Laryngeal Cancer.
    Megwalu UC; Panossian H
    Anticancer Res; 2016 Jun; 36(6):2903-7. PubMed ID: 27272804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the multidisciplinary tumor board on head and neck cancer outcomes.
    Liu JC; Kaplon A; Blackman E; Miyamoto C; Savior D; Ragin C
    Laryngoscope; 2020 Apr; 130(4):946-950. PubMed ID: 31095740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.